Rabia Malik to Self Administration
This is a "connection" page, showing publications Rabia Malik has written about Self Administration.
Connection Strength
0.047
-
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. JAMA Neurol. 2020 05 01; 77(5):582-592.
Score: 0.047